Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (5,794) Arrow Down
Filter Results: (5,794) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (5,794)
    • People  (19)
    • News  (2,251)
    • Research  (2,836)
    • Events  (3)
    • Multimedia  (224)
  • Faculty Publications  (1,991)

Show Results For

  • All HBS Web  (5,794)
    • People  (19)
    • News  (2,251)
    • Research  (2,836)
    • Events  (3)
    • Multimedia  (224)
  • Faculty Publications  (1,991)
← Page 96 of 5,794 Results →
  • Research Summary

Overview

By: Robert S. Kaplan
Kaplan introduced time-driven activity-based costing (TDABC) to provide the cost component in Michael Porter's Value Based Health Care framework of delivering superior patient outcomes at lower societal cost. TDABC is becoming the global standard for health care... View Details
  • Research Summary

Cost Management Systems

By: Robert S. Kaplan
Robert S. Kaplan continues to explore the design and use of activity-based cost management systems for manufacturing and service companies. His most recent work, done collaboratively with Professor Michael E. Porter, applies time-driven activity-based costing (TDABC)... View Details
  • 13 Oct 2016
  • Video

The Crash and the Fix of Healthcare.gov

  • December 2014 (Revised October 2017)
  • Case

Social Business at Novartis: Arogya Parivar

By: Michael E. Porter, Mark R. Kramer and David Lane
Late in 2013, Novartis CEO Joseph Jimenez was considering whether or how to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India while expanding access to medicine and health information to millions of... View Details
Keywords: Shared Value; India; Kenya; Vietnam; Novartis; Arogya Parivar; Social Business; Multinational Firms and Management; Competitive Advantage; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Viet Nam; Kenya; India
Citation
Educators
Purchase
Related
Porter, Michael E., Mark R. Kramer, and David Lane. "Social Business at Novartis: Arogya Parivar." Harvard Business School Case 715-411, December 2014. (Revised October 2017.)
  • 20 May 2016
  • News

MatchMiner Wins Harvard Business School Kraft Precision Trials Challenge

  • 31 Dec 2010
  • News

2010 James A. Hamilton Award from the American College of Healthcare Executives

  • 16 Oct 2013
  • News

Public Reporting, Consumerism, and Patient Empowerment

  • 26 Nov 2013
  • First Look

First Look: November 26

that increased the number of doctors and nurses serving patients, expanded existing staff roles and developed new ones, redistributed health care work, and invested in... View Details
Keywords: Sean Silverthorne
  • 25 Jul 2023
  • Research & Ideas

Could a Business Model Help Big Pharma Save Lives and Profit?

cross-sector and cross-border partnerships needed to execute the model. Adding new information about how pharmaceutical companies handle global public health challenges. Jessica Martinez, a former Big Pharma executive who joined the Bill... View Details
Keywords: by Esther Schrader; Health; Health
  • November 2011 (Revised May 2013)
  • Case

The Freelancers Union (A)

By: Michel Anteby and Erin McFee
Sara Horowitz faces a major strategic decision. Founder and CEO of the Freelancers Union, Horowitz has worked tirelessly to operationalize her new mutualist ideals, which comprise collective strength, independence, and shared protections. In 2008, she plans to move the... View Details
Keywords: Labor Unions
Citation
Educators
Purchase
Related
Anteby, Michel, and Erin McFee. "The Freelancers Union (A)." Harvard Business School Case 412-056, November 2011. (Revised May 2013.)
  • 25 Apr 2000
  • Research & Ideas

Adjusting the Fit for Government

pointed out. Panelist Dean Donovan, managing partner of Bain & Company in South Africa, said the imperatives for African governments are many, and are all intertwined. The key underpinnings include a health policy that deals with... View Details
Keywords: by Martha Lagace
  • Article

A Feasibility Study Using Time-driven Activity-based Costing as a Management Tool for Provider Cost Estimation: Lessons from the National TB Control Program in Zimbabwe in 2018

By: J. Chirenda, B. Nhlema Simwaka, C. Sandy, K. Bodnar, S. Corbin, P. Desai, T. Mapako, S. Shamu, C. Timire, E. Antonio, A. Makone, A. Birikorang, T. Mapuranga, M. Ngwenya, T. Masunda, M. Dube, E. Wandwalo, L. Morrison and R. S. Kaplan
Background: This study used process maps and time-driven activity-based costing to document TB service delivery processes. The analysis identified the resources required to sustain TB services in Zimbabwe, as well as several opportunities for more effective and... View Details
Keywords: Time-Driven Activity-Based Costing; Provider Cost; Health Care and Treatment; Cost Management; Activity Based Costing and Management; Zimbabwe
Citation
Read Now
Related
Chirenda, J., B. Nhlema Simwaka, C. Sandy, K. Bodnar, S. Corbin, P. Desai, T. Mapako, S. Shamu, C. Timire, E. Antonio, A. Makone, A. Birikorang, T. Mapuranga, M. Ngwenya, T. Masunda, M. Dube, E. Wandwalo, L. Morrison, and R. S. Kaplan. "A Feasibility Study Using Time-driven Activity-based Costing as a Management Tool for Provider Cost Estimation: Lessons from the National TB Control Program in Zimbabwe in 2018." BMC Health Services Research 21, no. 242 (2021).
  • 15 Sep 2016
  • News

Report: US government inaction is hampering economic growth

  • July 2010
  • Case

Metabical: Positioning and Communications Strategy for a New Weight Loss Drug

By: John A. Quelch and Heather Beckham
Cambridge Sciences Pharmaceuticals (CSP) expects final approval for its revolutionary weight loss drug, Metabical. Metabical will be the only weight loss drug with FDA approval that is also clinically proven to be effective for moderately overweight people. Barbara... View Details
Keywords: Product Positioning; Marketing Communications; Product Launch; Consumer Behavior; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Quelch, John A., and Heather Beckham. "Metabical: Positioning and Communications Strategy for a New Weight Loss Drug." Harvard Business School Brief Case 104-240, July 2010.
  • 23 Mar 2010
  • News

Robert Huckman on the Passage of U.S. Healthcare Reform Legislation

  • September 2022
  • Case

HPP: Tapping the Netherlands’ Potential

By: Brian Trelstad and Idelès Kaandorp
Stichting Het Potentieel Pakken (HPP) was launched to solve a systemic problem in the Dutch Labor Market: gender inequity that was leading to a large number of women to work part-time in fields that were in desperately short supply of labor, like health care, child... View Details
Keywords: COVID-19 Pandemic; Grants; Scaling And Growth; Nonprofit Organizations; Opportunities; Gender; Income; Employment; Health Care and Treatment; Human Capital; Mission and Purpose; Motivation and Incentives; Growth and Development Strategy; Health Industry; Health Industry; Health Industry; Health Industry; Europe; Netherlands
Citation
Educators
Purchase
Related
Trelstad, Brian, and Idelès Kaandorp. "HPP: Tapping the Netherlands’ Potential." Harvard Business School Case 323-024, September 2022.
  • 08 May 2013
  • News

Hospital Prices No Longer Secret As New Data Reveals Bewildering System, Staggering Cost Differences

  • 26 Nov 2019
  • News

Who Killed Healthcare? Dr Regina Herzlinger Knows Who’s Guilty

  • 16 Mar 2021
  • News

Employers Must Ensure the Safety of Home Workspaces

  • September 2022
  • Article

Trends in Remote Patient Monitoring Use in Traditional Medicare

By: Mitchell Tang, Carter Nakamoto, Ariel Dora Stern and Ateev Mehrotra
Remote patient monitoring (RPM), the collection by patients of physiological measurements that are automatically sent to their health care practitioners, has been touted as a promising tool for improving chronic disease management. Interest in RPM has grown because of... View Details
Keywords: Medicare; Remote Monitoring; Reimbursement; Health Care and Treatment; Health Industry
Citation
Find at Harvard
Purchase
Related
Tang, Mitchell, Carter Nakamoto, Ariel Dora Stern, and Ateev Mehrotra. "Trends in Remote Patient Monitoring Use in Traditional Medicare." JAMA Internal Medicine 182, no. 9 (September 2022): 1005–1006.
  • ←
  • 96
  • 97
  • …
  • 289
  • 290
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.